Articles from January 2024

Emmyon and Virbac identify a new nutritional approach that helps maintain healthy skeletal muscle and activity in dogs

Friday, January 26, 2024
Emmyon, a start-up company founded by Dr. Christopher Adams during his tenure at the University of Iowa, has announced the publication of an important new study conducted in collaboration with Virbac Corporation, an international leader in nutritional and pharmaceutical products for animal health.

Five tools to take your research to the next level in the new year

Thursday, January 25, 2024
Explore the resources available through the Office of the Vice President for Research to help researchers, scholars, and creators across our campus achieve their research goals.

Cardio Diagnostics Holdings, Inc. Announces the Grant of a Patent in India

Tuesday, January 16, 2024
Cardio Diagnostics Holdings, Inc. a pioneering AI-driven precision cardiovascular medicine company by UI faculty Dr. Robert Philibert and UI graduate Dr. Meesha Dogan, today announced that India’s Patent Office has granted a patent to the University of Iowa Research Foundation titled “A Kit for Determining Methylation Status of a CpG Dinucleotide and a Genotype of a Single Nucleotide Polymorphism."

Lantheus Expands Radiopharmaceutical Oncology Pipeline via Strategic Agreements with Perspective Therapeutics

Tuesday, January 16, 2024
Lantheus Holdings, Inc. today announced it has entered into multiple strategic agreements with Perspective Therapeutics, Inc., co-founded by UI Professor Mark Schultz and Dr. Frances Johnson, a radiopharmaceutical company that is pioneering advanced treatment applications for cancers throughout the body.